申请人:Hoechst Marion Roussel, Inc.
公开号:US05922737A1
公开(公告)日:1999-07-13
The present invention relates to novel substituted N-methyl-N-(4-(4-(1H-benzimidazol-2-yl-amino)piperidin-1-yl)-2-(aryl)butyl )benzamide derivatives of the formula: ##STR1## stereoisomers thereof, and pharmaceutically acceptable salts thereof which are useful as histamine receptor antagonists and tachykinin receptor antagonists. Such antagonists are useful in the treatment of allergic rhinitis, including seasonal rhinitis and sinusitis; inflammatory bowel diseases, including Crohn's disease and ulcerative colitis; asthma; bronchitis; and emesis.
本发明涉及一种新型的取代N-甲基-N-(4-(4-(1H-苯并咪唑-2-基氨基)哌啶-1-基)-2-(芳基)丁基)苯甲酰衍生物,其化学式为:##STR1## 其立体异构体,以及其药学上可接受的盐,可用作组胺受体拮抗剂和催吐受体拮抗剂。这些拮抗剂在过敏性鼻炎的治疗中有用,包括季节性鼻炎和鼻窦炎;炎症性肠道疾病,包括克罗恩病和溃疡性结肠炎;哮喘;支气管炎;以及呕吐。